Cellebrite DI Ltd.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $171.9m
$194.9m +13.42%
$246.2m +26.34%
$270.7m +9.91%
$325.1m +20.12%
$401.2m +23.41%
$475.7m +18.56%
$496.4m +4.36%
Cost of Revenue $35.8m
$37.9m +5.74%
$42.6m +12.35%
$50.7m +19.24%
$53.2m +4.90%
$62.6m +17.59%
$75.2m +20.10%
$80.1m +6.56%
Gross Profit, Total $136.0m
$157.0m +15.44%
$203.7m +29.71%
$219.9m +7.96%
$271.9m +23.63%
$338.6m +24.54%
$400.5m +18.28%
Research and Development Expense $46.6m $54.4m $65.5m $80.6m $84.4m $98.4m $113.9m $122.5m
Selling and Marketing Expense $61.6m $61.3m $76.4m $97.4m $110.8m $132.4m $154.8m $230.5m
General and Administrative Expense $29.4m $32.1m $47.9m $40.9m $43.4m $50.9m $65.3m $71.3m
Operating Expenses, Total $137.6m $147.8m $189.9m $218.9m $238.6m $281.7m $334.0m $353.0m
Operating Income (Loss), Total ($1.5m)
$9.2m +706.45%
$13.8m +49.95%
$1.0m -92.45%
$33.2m +3083.62%
$56.9m +71.21%
$66.5m +16.82%
$63.3m -4.74%
Nonoperating Income (Expense) $2.9m $2.2m $68.5m $119.7m ($108.8m) ($332.9m) $24.2m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total $1.4m $11.4m $82.3m $120.8m ($75.6m) ($276.0m) $90.7m $85.0m
Income Tax Expense (Benefit) $3.3m $5.6m $10.9m ($45k) $5.5m $7.0m $12.4m $13.1m
Net Income (Loss) ($1.9m)
$5.8m +408.16%
$71.4m +1135.01%
$120.8m +69.20%
($81.1m) -167.13%
($283.0m) -248.96%
$78.3m +127.68%
$71.4m -8.91%
Basic net income (loss) per ordinary share (in USD per share) ($0) ($0) $0 $1 ($0) ($1) $0
Diluted net income (loss) per share (in USD per share) ($0) ($0) $0 $1 ($0) ($1) $0
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares) ($0) $0 $0 $1 ($0) ($1) $0
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares) ($0) $0 $0 $1 ($0) ($1) $0
Basic net income (loss) per share attributable to ordinary shareholders $0 ($1) $1 $1 $1 $1 $1